• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Stahl's Illustrated Antidepressants

Stahl's Illustrated Antidepressants

9780521758529
314,94 zł
283,44 zł Zniżka 31,50 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 283,44 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
All of the titles in the Stahls Illustrated Series are designed to be fun. Concepts are illustrated by full-color images that will be familiar to all readers of Stahls Essential Psychopharmacology, 3rd Edition and The Prescribers Guide. The texts in this user-friendly series can be supplements to figures, images, and tables. The visual learner will find that these books make psychopharmacology concepts easy to master, while the non-visual learner will enjoy a shortened text version of complex psychopharmacology concepts. Within each book, each chapter builds on previous chapters, synthesizing information from basic biology and diagnostics to building treatment plans and dealing with complications and comorbidities. Novices may want to approach Stahls Illustrated Series by first looking through all the graphics and gaining a feel for the visual vocabulary. Readers more familiar with these topics should find that going back and forth between images and text provides an interaction with which to vividly conceptualize complex pharmacologies. And, to help guide the reader toward more in-depth learning about particular concepts, each book ends with a Suggested Reading section.
Szczegóły produktu
97710
9780521758529
9780521758529

Opis

Rok wydania
2009
Numer wydania
1
Oprawa
miękka foliowana
Liczba stron
200
Wymiary (mm)
148.00 x 207.00
Waga (g)
290
  • 1. Neurobiology of depression; 2. Selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs); 3. Norepinephrine and dopamine reuptake inhibitors (NDRIs) and selective norepinephrine reuptake inhibitors (NRIs); 4. Alpha 2 antagonists as serotonin and norepinephrine; 5. Monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants (TCAs); 6. Building a treatment plan with novel treatment and augmentation options for depression; 7. Depression in women:: treating symptoms throughout the life span; 8. Pharmacokinetics and algorithms to treat depression.
Komentarze (0)